HRP20050195B1 - Makrolidni spojevi s protuupalnim djelovanjem - Google Patents

Makrolidni spojevi s protuupalnim djelovanjem

Info

Publication number
HRP20050195B1
HRP20050195B1 HRP20050195AA HRP20050195A HRP20050195B1 HR P20050195 B1 HRP20050195 B1 HR P20050195B1 HR P20050195A A HRP20050195A A HR P20050195AA HR P20050195 A HRP20050195 A HR P20050195A HR P20050195 B1 HRP20050195 B1 HR P20050195B1
Authority
HR
Croatia
Prior art keywords
antiinflammatory activity
macrolide compounds
compounds endowed
macrolide
endowed
Prior art date
Application number
HRP20050195AA
Other languages
English (en)
Inventor
Mauro Napoletano
Ermanno Moriggi
Andrea Mereu
Fernando Ornaghi
Gabriele Morazzoni
Roberto Longoni
Carlo Riva
Luciano Pacchetti
Franco Pellacini
Original Assignee
Zambon Group S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S.P.A. filed Critical Zambon Group S.P.A.
Publication of HRP20050195A2 publication Critical patent/HRP20050195A2/hr
Publication of HRP20050195B1 publication Critical patent/HRP20050195B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Opisani su makrolidni spojevi obdareni protuupalnim djelovanjem, a osobito makrolidni derivati s protuupalnim djelovanjem, koji nemaju kladinozu u položaju 3, njihove farmaceutski prihvatljive soli i farmaceutski sastavi koji ih sadrže kao djelotvorne agense.
HRP20050195AA 2002-08-01 2005-02-28 Makrolidni spojevi s protuupalnim djelovanjem HRP20050195B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001726A ITMI20021726A1 (it) 2002-08-01 2002-08-01 Macrolidi ad attivita' antiinfiammatoria.
PCT/EP2003/008448 WO2004013153A2 (en) 2002-08-01 2003-07-29 Macrolide compounds endowed with antiinflammatory activity

Publications (2)

Publication Number Publication Date
HRP20050195A2 HRP20050195A2 (en) 2005-12-31
HRP20050195B1 true HRP20050195B1 (hr) 2013-10-25

Family

ID=31198615

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20050195AA HRP20050195B1 (hr) 2002-08-01 2005-02-28 Makrolidni spojevi s protuupalnim djelovanjem

Country Status (18)

Country Link
US (2) US7488811B2 (hr)
EP (2) EP1529053B1 (hr)
JP (1) JP4589110B2 (hr)
KR (1) KR101051369B1 (hr)
CN (1) CN100335491C (hr)
AT (1) ATE509938T1 (hr)
AU (1) AU2003269861B2 (hr)
BR (1) BR0313162A (hr)
CA (1) CA2493995C (hr)
CO (1) CO5720000A2 (hr)
ES (1) ES2364647T3 (hr)
HR (1) HRP20050195B1 (hr)
IL (1) IL166527A0 (hr)
IT (1) ITMI20021726A1 (hr)
NZ (1) NZ537992A (hr)
PT (1) PT1529053E (hr)
RU (1) RU2330856C2 (hr)
WO (1) WO2004013153A2 (hr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
WO2004019879A2 (en) * 2002-08-29 2004-03-11 Kosan Biosciences, Inc. Motilide compounds
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7407941B2 (en) 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
ITMI20040124A1 (it) * 2004-01-29 2004-04-29 Zambon Spa Macrolidi ad attivita' antiinfiammatoria
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
CN108101948A (zh) * 2004-02-27 2018-06-01 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
DE602006004555D1 (de) * 2005-01-13 2009-02-12 Glaxosmithkline Zagreb Decladinosyl-macrolide mit entzündungshemmender wirkung
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
CN102295671B (zh) * 2005-07-06 2014-01-29 萨宝公司 具有抗炎活性的大环内酯化合物的晶形
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
WO2007025284A1 (en) * 2005-08-24 2007-03-01 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
RS53666B1 (en) 2005-10-19 2015-04-30 Teva Pharmaceutical Industries Ltd CRYSTALS OF SODIUM LAKVINIMOD AND THE PROCESS FOR OBTAINING THEM
AU2006323175A1 (en) * 2005-12-08 2007-06-14 Pfizer, Inc. Method for demethylating the 3'-dimethylamino group of erythromycin compounds
JP5126685B2 (ja) * 2006-05-01 2013-01-23 大正製薬株式会社 マクロライド誘導体
WO2008143729A2 (en) * 2007-02-28 2008-11-27 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
BRPI0908343A2 (pt) 2008-02-08 2020-08-18 Basilea Pharmaceutica Ag macrolídeos e seu uso
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
US20110281812A1 (en) 2009-01-30 2011-11-17 Sulejman Alihodzic Compounds
AR075340A1 (es) 2009-01-30 2011-03-23 Glaxosmithkline Zagreb 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a,formas cristalinas 1, 2 y 3, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamento util para el tratamiento de enfermedades inflamatorias
US8865662B2 (en) 2009-08-13 2014-10-21 Basilea Pharmaceutica Ag Macrolides and their use
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
CA2890194A1 (en) 2012-11-07 2014-05-15 Teva Pharmaceutical Industries Ltd. Amine salts of laquinimod
US20160046582A1 (en) 2013-03-14 2016-02-18 Teva Pharmaceutical Industries Ltd. Crystals of laquinimod sodium and improved process for the manufacture thereof
WO2014166503A1 (en) * 2013-04-10 2014-10-16 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
WO2021138847A1 (en) * 2020-01-08 2021-07-15 Beijing Continent Pharmaceuticals Co., Ltd. Macrolide compound and its use of treatment chronic respiratory disease

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
US4743593A (en) * 1984-12-08 1988-05-10 Beecham Group P.L.C. 9,11-O-methylene derivatives of 9-dihydroerythromycin
EP0682038A1 (en) * 1993-01-26 1995-11-15 Taisho Pharmaceutical Co. Ltd 5-o-desosaminylerythronolide derivative
FR2735694A1 (fr) * 1995-06-20 1996-12-27 Roussel Uclaf Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant
US5969161A (en) * 1995-09-11 1999-10-19 Hoechst Marion Roussel 5-O-deaominyl 6-O-methyl erythronolide a derivatives, method for preparing same and application thereof for preparing biologically active products
WO2000042055A2 (en) * 1999-01-15 2000-07-20 Zambon Group S.P.A. Macrolides with anti-inflammatory activity
JP2001181294A (ja) * 1999-12-27 2001-07-03 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US3623784A (en) * 1969-11-05 1971-11-30 Massey Ferguson Ind Ltd Cabinet joint structure
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
US3928387A (en) 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
EP0254534A3 (en) 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
WO1992016226A1 (en) 1991-03-19 1992-10-01 Smithkline Beecham Corporation Il-1 inhibitors
US6096715A (en) * 1993-05-07 2000-08-01 City Of Hope Chimeric DNA-RNA catalytic sequences
KR970704455A (ko) 1994-08-12 1997-09-06 우에하라 아끼라 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)
AU3192695A (en) 1994-08-12 1996-03-07 Taisho Pharmaceutical Co., Ltd. Interleukin-5 production inhibitor
IT1276901B1 (it) 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
AU714176B2 (en) * 1995-11-08 1999-12-23 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
DK1025114T3 (da) 1997-09-30 2004-07-05 Abbott Lab 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet
JPH11236395A (ja) * 1997-12-11 1999-08-31 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US5892008A (en) * 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
ATE275151T1 (de) 1998-03-03 2004-09-15 Pfizer Prod Inc 3,6-ketal-makrolidantibiotika
DE19910159A1 (de) 1999-02-26 2000-09-14 Rosemarie Heis Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung
JP2000351793A (ja) * 1999-06-09 2000-12-19 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060043226A1 (en) * 2004-08-24 2006-03-02 Keith Roozeboom Apparatus and method for grinding with staggered cutters
US7096915B2 (en) * 2004-11-05 2006-08-29 Hsiu-Man Yu Chen Tape-roll supporting device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
US4743593A (en) * 1984-12-08 1988-05-10 Beecham Group P.L.C. 9,11-O-methylene derivatives of 9-dihydroerythromycin
EP0682038A1 (en) * 1993-01-26 1995-11-15 Taisho Pharmaceutical Co. Ltd 5-o-desosaminylerythronolide derivative
FR2735694A1 (fr) * 1995-06-20 1996-12-27 Roussel Uclaf Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant
US5969161A (en) * 1995-09-11 1999-10-19 Hoechst Marion Roussel 5-O-deaominyl 6-O-methyl erythronolide a derivatives, method for preparing same and application thereof for preparing biologically active products
WO2000042055A2 (en) * 1999-01-15 2000-07-20 Zambon Group S.P.A. Macrolides with anti-inflammatory activity
JP2001181294A (ja) * 1999-12-27 2001-07-03 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体

Also Published As

Publication number Publication date
CA2493995A1 (en) 2004-02-12
WO2004013153A2 (en) 2004-02-12
WO2004013153A3 (en) 2004-04-08
EP1529053A2 (en) 2005-05-11
JP2005538998A (ja) 2005-12-22
AU2003269861B2 (en) 2010-01-21
AU2003269861A1 (en) 2004-02-23
CN1678620A (zh) 2005-10-05
CN100335491C (zh) 2007-09-05
KR20050037567A (ko) 2005-04-22
ITMI20021726A1 (it) 2004-02-02
CO5720000A2 (es) 2007-01-31
ATE509938T1 (de) 2011-06-15
NZ537992A (en) 2007-11-30
EP2258708A1 (en) 2010-12-08
BR0313162A (pt) 2005-07-05
CA2493995C (en) 2011-01-04
RU2330856C2 (ru) 2008-08-10
HRP20050195A2 (en) 2005-12-31
JP4589110B2 (ja) 2010-12-01
IL166527A0 (en) 2006-01-15
US20090054357A1 (en) 2009-02-26
US7488811B2 (en) 2009-02-10
ES2364647T3 (es) 2011-09-08
US7704960B2 (en) 2010-04-27
RU2005105592A (ru) 2005-08-27
US20060058246A1 (en) 2006-03-16
KR101051369B1 (ko) 2011-07-22
EP1529053B1 (en) 2011-05-18
PT1529053E (pt) 2011-07-05

Similar Documents

Publication Publication Date Title
IL166527A0 (en) Macrolide compounds endowed with antiinflammatory activity
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
PL376154A1 (en) Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
DE69915487D1 (de) Erythromycin-derivate mit antibiotischer wirkung
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
TWI340167B (en) Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
HUP0303673A3 (en) Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2001228810A1 (en) Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
HUP0202725A3 (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity, process for their preparation and pharmaceutical compositions containing them
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
AU2001287489A1 (en) New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments
AU1999301A (en) Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for theirproduction and use thereof
ATE254625T1 (de) Eythromycinderivat mit antibiotischer aktvität

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20130709

Year of fee payment: 11

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20140729